Home Tags GW Pharmaceuticals

Tag: GW Pharmaceuticals

epidiolex_legal_CBDToday

Key DEA Change Could Make Cannabinoid-Based Medicine More Accessible 

Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.
New Frontier Data-webinar-coronavirus-CBD-CBDToday

New Frontier Webinar Focuses on Risk, Opportunity Amid Coronavirus Crisis

Marketing data firm New Frontier Data yesterday hosted a day-long webinar on the effect of the coronavirus (COVID-19) crisis on the global cannabis and...
Department of Transportation-Policy-CBD products-CBDToday

Dept. of Transportation Issues Compliance Notice on CBD Use

WASHINGTON, D.C. – The U.S. Department of Transportation (DOT) issued a compliance notice on Tuesday addressing use of CBD-infused products for “safety sensitive employees.” Employees...
FDA-Update-CBD-CBDToday

FDA Provides Update on CBD Position

WASHINGTON, D.C. – The Food and Drug Administration (FDA) has provided an update regarding its stance on hemp and CBD. Although hemp containing less...
Medical Claims cbd today

Risky Business: CBD Health Claims Can Land Marketers in Federal Trouble

Marketing CBD products presents a quandary. CBD doesn’t cause an altered mental state, so it seems obvious products containing the substance are intended for...
spa session CBDToday

Disillusioned with Big Pharma, Consumers Take Control of Their Own Health

The cannabinoid tetrahydrocannabinol (THC), the psychoactive compound in cannabis, used to get all the attention. But cannabidiol, more commonly known as CBD, has gained...
Advertisement
KushyCBD

TOP STORIES